Hypopharyngeal cancer mri: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Hypopharyngeal cancer}} | {{Hypopharyngeal cancer}} | ||
{{CMG}} {{AE}}{{Faizan}} | {{CMG}} {{AE}}{{Faizan}} | ||
MRI | |||
MRI has the ability to be superior to CT in local staging and assessing perineural spread however relatively long acquisition times and degradation by motion artefact are sometimes challenging 3. | |||
T1: intermediate to low signal mass | |||
T2: intermediate to high signal | |||
T1 C+ (GAD): | |||
enhancement usually present | |||
larger tumours of nodal metastases may be centrally necrotic | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 14:26, 30 September 2015
|
Hypopharyngeal cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypopharyngeal cancer mri On the Web |
|
American Roentgen Ray Society Images of Hypopharyngeal cancer mri |
|
Risk calculators and risk factors for Hypopharyngeal cancer mri |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
MRI
MRI has the ability to be superior to CT in local staging and assessing perineural spread however relatively long acquisition times and degradation by motion artefact are sometimes challenging 3.
T1: intermediate to low signal mass T2: intermediate to high signal T1 C+ (GAD): enhancement usually present larger tumours of nodal metastases may be centrally necrotic